Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-27T14:01:36.740Z Has data issue: false hasContentIssue false
  • English
  • Français

Mid-term results of percutaneous ventricular septal defect closure with Amplatzer Duct Occluder-II in children

Published online by Cambridge University Press:  20 June 2017

Ozge Pamukcu ,
Nazmi Narin ,
Ali Baykan ,
Suleyman Sunkak ,
Onur Tasci  and
Kazim Uzum
Ozge Pamukcu*
Affiliation:
Division of Pediatric Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
Nazmi Narin
Affiliation:
Division of Pediatric Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
Ali Baykan
Affiliation:
Division of Pediatric Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
Suleyman Sunkak
Affiliation:
Division of Pediatric Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
Onur Tasci
Affiliation:
Division of Pediatric Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
Kazim Uzum
Affiliation:
Division of Pediatric Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
*
Correspondence to: O. Pamukcu, MD, Division Pediatric Cardiology, Erciyes University School of Medicine, Kayseri 38350, Turkey. Tel: +0903522076666-25036; Fax: +0903524375825; E-mail: ozgepamukcu2002@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Aim

The aim of this study was to share the mid-term results of percutaneous ventricular septal defect closure using Amplatzer Duct Occluder-II in children.

Background

Nowadays, percutaneous ventricular septal defect closure is accepted as an alternative to surgery, but so far no ideal device has been developed for this procedure.

Methods

In the study centre, between April, 2011 and October, 2016, the ventricular septal defect of 49 patients was closed percutaneously using the Amplatzer Duct Occluder-II device, and seven of them were <1 year old.

Results

The mean age of patients was 86.8±52.6 months. The mean weight of the patients was 24.3±16 kg. The mean diameter of the defect was 3.7±1.4 mm. Mean fluoroscopy time and total procedure time were 37±19.3 and 74.1±27 minutes, respectively. The types of ventricular septal defects were muscular in six patients, and were perimembranous in the rest of them. We did not face any major complications during the procedure, but one patient was admitted with a complete atrioventricular block in the 6th month of follow-up. The total follow-up period was 66 months.

Conclusion

To our knowledge, our study includes the largest series of paediatric patients whose ventricular septal defect was closed using Amplatzer Duct Occluder-II percutaneously. When the complications during the 66-month follow-up period are taken into consideration, we can state that Amplatzer Duct Occluder-II is a safe and effective device, even in infants aged <1 year.

Keywords

Childrenpercutaneousclosure
Type
Original Articles
Information
Cardiology in the Young , Volume 27 , Issue 9 , November 2017 , pp. 1726 - 1731
Check for updates
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Scully, BB, Morales, DL, Zafar, F, et al. Current expectations for surgical repair of isolated ventricular septal defects. Ann Thorac Surg 2010; 89: 544–549; discussion 550–551.Google Scholar
2. Lock, JE, Block, PC, McKay, RG, Baim, DS, Keane, JF. Transcatheter closure of ventricular septal defects. Circulation 1998; 78: 361–368.CrossRefGoogle Scholar
3. O’Laughlin, MP, Mullins, CE. Transcatheter occlusion of ventricular septal defect. Cathet Cardiovasc Diagn 1989; 17: 175–179.CrossRefGoogle ScholarPubMed
4. Celiker, A, Ozkutlu, S, Karagoz, T, et al. Device closure of congenital ventricular septal defects with Amplatzer devices: first experiences in Turkey. Turk J Pediatr 2008; 50: 106–113.Google ScholarPubMed
5. Butera, G, Carminati, M, Chessa, M, et al. Percutaneous closure of ventricular septal defects in children aged <12: early and midterm results. Eur Heart J 2006; 27: 2889–2895.Google Scholar
6. Narin, N, Baykan, A, Pamukcu, O, et al. ADO II in percutaneous ventricular septal defect closure in pediatric patients. J Interv Cardiol 2015; 28: 479–484.CrossRefGoogle Scholar
7. Fischer, G, Apostolopoulou, SC, Rammos, S, et al. The Amplatzer membranous ventricular septal defect occluder and the vulnerability of the atrioventricular conduction system. Cardiol Young 2007; 17: 499–504.Google Scholar
8. Andersen, HQ, Leval, MR, Tsang, VT, et al. Is complete heart block after surgical closure of ventricular septal defects still an issue? Ann Thorac Surg 2006; 82: 948–956.Google Scholar
9. Saurav, A, Kaushik, M., Mahesh Alla, V, et al. Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2015; 86: 1048–1056.CrossRefGoogle ScholarPubMed
10. Fu, YC, Bass, J, Amin, Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous ventricular septal defect occluder results of the U.S. Phase I Trial. J Am Coll Cardiol 2006; 47: 319–325.Google Scholar
11. Butera, G, Carminati, M, Chessa, M, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long term results. J Am Coll Cardiol 2007; 50: 1189–1195.Google Scholar
12. Yang, R, Kong, XQ, Sheng, YH, et al. Risk factors and outcomes of postprocedure heart blocks after transcatheter device closure of perimembranous ventricular septal defect. JACC Cardiovasc Interv 2012; 5: 422–427.Google Scholar
13. Vijayalakshmi, IB, Narasimhan, C, Singh, B, et al. Treatment of congenital non-ductal shunt lesions with the Amplatzer Duct Occluder II. Catheter Cardiovasc Interv 2017; 89: 185–193.Google Scholar
14. Freedman, SB, Haladyn, JK, Floh, A, et al. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics 2007; 120: 1278–1285.Google Scholar
15. Batra, AS, Epstein, D, Silka, MJ. The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol 2003; 24: 495–497.Google ScholarPubMed
16. Ichikawa, R, Sumitomo, N, Komori, A, et al. The follow-up evaluation of electrocardiogram and arrhythmias in children with fulminant myocarditis. Circ J 2011; 75: 932–938.CrossRefGoogle ScholarPubMed
17. Kanaan, M, Ewert, P, Berger, F, et al. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II. Pediatr Cardiol 2015; 36: 379–385.Google Scholar